Life-threatening illness in a nontransfusable patient: a health care challenge.
Olivencia
G
G
VA Medical Center, Hampton, USA.
D015746:Abdominal Pain / Q000209:etiology; D000328:Adult; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects; D018798:Anemia, Iron-Deficiency / Q000209:etiology / Q000517:prevention & control; D001064:Appendicitis / Q000150:complications / Q000601:surgery; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use; D005334:Fever / Q000209:etiology; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000150:complications / Q000517:prevention & control; D005921:Glomerulonephritis / Q000150:complications; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications; D007052:Ibuprofen / Q000009:adverse effects; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy; D008297:Male; D009733:Nursing Diagnosis; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods / Q000451:nursing
D018712:Analgesics, Non-Narcotic; D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa; D007052:Ibuprofen